
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
LIPOSOMES: A NOVEL APPROACH AS A CARRIER
Rajiv Kumar Arora*, Vivek Kumar, Rishi Pal and Parveen Ruhil*
Abstract Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were first described in the mid-60s. Today, they are a very important tool in various scientific disciplines. Among several talented new drug delivery systems, liposomes characterize an advanced technology to deliver active molecules to the site of action. Liposomes, which are biodegradable and essentially non‐toxic vehicles, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers in drug delivery systems. As a result, numerous improvements have been made, thus making this technology potentially useful for the treatment of certain diseases in the clinics. Many liposome‐based DNA delivery systems have been described, including molecular components for targeting given cell surface receptors or for escaping from the lysosomal compartment. The insight gained from clinical use of liposome drug delivery systems can now be integrated to design liposomes that can be targeted on tissues, cells or intracellular compartments with or without expression of target recognition molecules on liposome membranes. The success of liposomes as drug carriers has been reflected in a number of liposome‐based formulations, which are commercially available or are currently undergoing clinical trials. Keywords: Liposomes; delivery systems; drug; target. [Full Text Article] [Download Certificate] |
